Primary |
Pain |
44.2% |
Product Used For Unknown Indication |
27.0% |
Hypertension |
4.5% |
Back Pain |
3.2% |
Prophylaxis |
2.0% |
Prophylaxis Of Nausea And Vomiting |
2.0% |
Myocardial Infarction |
1.8% |
Insomnia |
1.5% |
Osteoporosis |
1.5% |
Constipation |
1.4% |
Depression |
1.4% |
Pain In Extremity |
1.3% |
Bipolar Disorder |
1.1% |
Hyperlipidaemia |
1.1% |
Occupational Exposure To Product |
1.1% |
Diabetes Mellitus |
1.0% |
Diabetic Neuropathy |
1.0% |
Emphysema |
1.0% |
Gastritis |
1.0% |
Psychiatric Symptom |
1.0% |
|
Nausea |
9.2% |
Renal Impairment |
9.2% |
Vomiting |
9.2% |
Loss Of Consciousness |
8.2% |
Interstitial Lung Disease |
7.1% |
Asthma |
5.1% |
Gastric Ulcer |
5.1% |
Somnolence |
5.1% |
Cardiac Failure |
4.1% |
Hallucination |
4.1% |
Hepatic Function Abnormal |
4.1% |
Inappropriate Schedule Of Drug Administration |
4.1% |
Treatment Noncompliance |
4.1% |
Hospitalisation |
3.1% |
International Normalised Ratio Increased |
3.1% |
Liver Disorder |
3.1% |
Malaise |
3.1% |
Pain |
3.1% |
Personality Change |
3.1% |
Pneumonia Aspiration |
3.1% |
|
Secondary |
Pain |
45.0% |
Product Used For Unknown Indication |
10.9% |
Myocardial Infarction |
6.4% |
Cancer Pain |
5.9% |
Hypertension |
5.2% |
Trigeminal Neuralgia |
4.9% |
Depression |
2.2% |
Osteoporosis |
2.1% |
Spinal Column Stenosis |
2.1% |
Prophylaxis |
2.0% |
Lumbar Spinal Stenosis |
1.9% |
Hyperlipidaemia |
1.6% |
Post Herpetic Neuralgia |
1.6% |
Back Pain |
1.5% |
Insomnia |
1.5% |
Constipation |
1.4% |
Analgesic Therapy |
1.2% |
Bipolar Disorder |
0.9% |
Emphysema |
0.9% |
Gastritis |
0.8% |
|
Prothrombin Time Prolonged |
11.1% |
Vomiting |
11.1% |
Inappropriate Schedule Of Drug Administration |
7.8% |
Gastric Ulcer |
6.7% |
Nausea |
6.7% |
Off Label Use |
5.6% |
Pain |
5.6% |
Treatment Noncompliance |
5.6% |
Liver Disorder |
4.4% |
Pancreatic Carcinoma |
4.4% |
Somnolence |
4.4% |
White Blood Cell Count Decreased |
4.4% |
Delusion |
3.3% |
Drug-induced Liver Injury |
3.3% |
Prerenal Failure |
3.3% |
Toxicity To Various Agents |
3.3% |
Asthma |
2.2% |
Femoral Neck Fracture |
2.2% |
Haematemesis |
2.2% |
Insomnia |
2.2% |
|
Concomitant |
Product Used For Unknown Indication |
31.4% |
Rheumatoid Arthritis |
8.2% |
Pain |
6.7% |
Prophylaxis |
6.2% |
Hiv Infection |
5.9% |
Spinal Osteoarthritis |
4.7% |
Chronic Hepatitis C |
4.1% |
Constipation |
3.5% |
Extradural Abscess |
3.5% |
Insomnia |
3.5% |
Psoriatic Arthropathy |
2.6% |
Analgesic Therapy |
2.3% |
Anxiety Disorder |
2.3% |
Gastritis |
2.3% |
Herpes Zoster |
2.3% |
Mental Disorder |
2.3% |
Nephrogenic Anaemia |
2.3% |
Prophylaxis Against Gastrointestinal Ulcer |
2.1% |
Diabetes Mellitus |
1.8% |
Hypertension |
1.8% |
|
White Blood Cell Count Decreased |
13.9% |
Interstitial Lung Disease |
11.1% |
Spinal Compression Fracture |
8.3% |
Meningitis |
5.6% |
Pneumothorax |
5.6% |
Pyrexia |
5.6% |
Renal Failure |
5.6% |
Restlessness |
5.6% |
Stevens-johnson Syndrome |
5.6% |
Tinnitus |
5.6% |
Cerebellar Atrophy |
2.8% |
Cholecystitis |
2.8% |
Delirium |
2.8% |
Dementia |
2.8% |
Disseminated Intravascular Coagulation |
2.8% |
Ectopic Pregnancy |
2.8% |
Fatigue |
2.8% |
Haematochezia |
2.8% |
Herpes Zoster |
2.8% |
Hyponatraemia |
2.8% |
|
Interacting |
Bipolar Ii Disorder |
50.0% |
Depression |
10.0% |
Low Back Pain |
10.0% |
Neuropathic Pain |
10.0% |
Bronchopulmonary Aspergillosis |
5.0% |
Hypertension |
5.0% |
Post Herpetic Neuralgia |
5.0% |
Rheumatic Disorder |
5.0% |
|
Suicide Attempt |
50.0% |
Drug Interaction |
25.0% |
Road Traffic Accident |
25.0% |
|